Blueprint Medicines (BPMC) PT Lowered to $151 at Wells Fargo
Tweet
Share
E-mailGet Alerts BPMC Hot Sheet
Price: $129.46 --0%
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wells Fargo analyst Derek Archila lowered the price target on Blueprint Medicines (NASDAQ: BPMC) to $151.00 (from $153.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
